Showing results (441-450 of 1,835) with videos related to

Sort By:
Pageof 184
ESMO Open|July 15, 2020
Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastomaPatrick Yung Wen, Jordi A Rodon, Warren Mason, et al.
ESMO Open|September 4, 2025
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B studyV Martelli, J Vidal, J Gibert, et al.
ESMO Open|January 13, 2018
Biology of premature ageing in survivors of cancerMargaret C Cupit-Link, James L Kirkland, Kirsten K Ness, et al.
ESMO Open|January 16, 2018
Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomasHerbert H Loong, Kwan-Hung Wong, Teresa Tse
ESMO Open|March 14, 2018
Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinomaMarc Peeters, Frédéric Forget, Meinolf Karthaus, et al.
ESMO Open|March 14, 2018
Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutationsSatoshi Oizumi, Shunichi Sugawara, Koichi Minato, et al.
ESMO Open|March 14, 2018
Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage IMartin Fehr, Angela Fischer Maranta, Hermann Reichegger, et al.
ESMO Open|February 2, 2018
Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussionMatthias Preusser, Frank Winkler, Manuel Valiente, et al.
ESMO Open|February 2, 2018
Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive marginsAnna Torgeson, Ignacio Garrido-Laguna, Randa Tao, et al.
ESMO Open|February 2, 2018
Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2Isabella C Glitza, Michelle Rohlfs, Nandita Guha-Thakurta, et al.
Pageof 184